Darwin Global Management, Ltd.

Position in DNTH — Dianthus Therapeutics, Inc. /DE/

CIK 1839209 ST. HELIER, Y9

Position in DNTH

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,456,599

New position

Shares Held

17,357

first reported quarter

Ownership

0.032%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Darwin Global Management, Ltd. holds $4,026,455,721 across 6 Biotechnology names. DNTH ranks #6 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	16,805,184	$2,747,983,687
2	BLTE	Belite Bio, Inc	3,057,412	$487,473,769
3	ABVX	Abivax S.A.	3,468,657	$386,234,956
4	RVMD	Revolution Medicines, Inc.	2,211,018	$215,021,500
5	ROIV	Roivant Sciences Ltd.	6,797,300	$188,285,210
6	DNTH	Dianthus Therapeutics, Inc. /DE/ This page	17,357	$1,456,599

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,456,599	17,357	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.